SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The study will involve administering the study drug as a single dose of study drug or placebo. This study is designed to demonstrate the superiority of the experimental drug versus placebo in adult patients with recurrent CDI.
Epistemonikos ID: 244e3b951b9a2d9667ee363d834b7ea47b58a2fd
First added on: May 12, 2024